[go: up one dir, main page]

NO903058D0 - Farmasoeytisk preparat med forbedret absorberbarhet. - Google Patents

Farmasoeytisk preparat med forbedret absorberbarhet.

Info

Publication number
NO903058D0
NO903058D0 NO903058A NO903058A NO903058D0 NO 903058 D0 NO903058 D0 NO 903058D0 NO 903058 A NO903058 A NO 903058A NO 903058 A NO903058 A NO 903058A NO 903058 D0 NO903058 D0 NO 903058D0
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
improved absorbability
absorbability
improved
chem
Prior art date
Application number
NO903058A
Other languages
English (en)
Other versions
NO177484C (no
NO177484B (no
NO903058L (no
Inventor
Keizo Uesugu
Masanori Kayano
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO903058D0 publication Critical patent/NO903058D0/no
Publication of NO903058L publication Critical patent/NO903058L/no
Publication of NO177484B publication Critical patent/NO177484B/no
Publication of NO177484C publication Critical patent/NO177484C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO903058A 1989-07-10 1990-07-09 Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler NO177484C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17732489 1989-07-10

Publications (4)

Publication Number Publication Date
NO903058D0 true NO903058D0 (no) 1990-07-09
NO903058L NO903058L (no) 1991-01-11
NO177484B NO177484B (no) 1995-06-19
NO177484C NO177484C (no) 1995-09-27

Family

ID=16028989

Family Applications (1)

Application Number Title Priority Date Filing Date
NO903058A NO177484C (no) 1989-07-10 1990-07-09 Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler

Country Status (13)

Country Link
US (1) US5139740A (no)
EP (1) EP0407815B1 (no)
JP (1) JP3048602B2 (no)
KR (1) KR930000048B1 (no)
CN (1) CN1041600C (no)
AT (1) ATE88902T1 (no)
CA (1) CA2020261A1 (no)
DE (1) DE69001513T2 (no)
DK (1) DK0407815T3 (no)
ES (1) ES2055227T3 (no)
FI (1) FI96169C (no)
GR (1) GR3007793T3 (no)
NO (1) NO177484C (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI901046A7 (fi) * 1989-03-17 1990-09-18 Eisai Co Ltd Polyprenyyliyhdisteen stabiloiminen
WO1992017185A1 (en) * 1991-03-29 1992-10-15 University Of Florida Targeted drug delivery via mixed phosphate derivatives
IT1263840B (it) * 1993-03-30 1996-09-04 Giuseppe Furiosi Formulazioni orali di ubidecarenone in forma di capsule
HUP0003528A3 (en) * 1996-12-12 2001-07-30 Upjohn Co Pharmaceutical compositions containing dihydropolyprenols
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
WO2005016312A1 (en) 2003-08-13 2005-02-24 Nobex Corporation Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
KR102162901B1 (ko) 2011-09-29 2020-10-08 피엘엑스 옵코 인코포레이티드 위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
MX2022011743A (es) 2020-03-26 2022-12-08 Plx Opco Inc Portadores farmaceuticos con capacidad de reconstitucion dependiente del ph y metodos para elaborar y usar los mismos.
WO2025219169A1 (en) 2024-04-16 2025-10-23 Bayer Consumer Care Ag Stable soft capsule preparations with liquid fill for moisture sensitive active ingredients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2746087A1 (de) * 1977-10-13 1979-04-26 Chinoin Gyogyszer Es Vegyeszet Cyclodextrin-einschlusskomplexe mit indomethacin, verfahren zu ihrer herstellung und pharmazeutische mittel
JPS5815940A (ja) * 1981-07-23 1983-01-29 Eisai Co Ltd ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
DE3500103C2 (de) * 1985-01-04 1987-01-22 R.P. Scherer GmbH, 6930 Eberbach Pharmazeutische Zubereitung mit einem in Wasser und Verdauungssäften schwer löslichen Wirkstoff
IE59067B1 (en) * 1985-04-02 1993-12-15 Yesair David W Composition for delivery of orally administered drugs and other substances
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems

Also Published As

Publication number Publication date
EP0407815B1 (en) 1993-05-05
CA2020261A1 (en) 1991-01-11
DE69001513D1 (de) 1993-06-09
CN1048656A (zh) 1991-01-23
JP3048602B2 (ja) 2000-06-05
EP0407815A2 (en) 1991-01-16
NO177484C (no) 1995-09-27
DE69001513T2 (de) 1993-10-28
ATE88902T1 (de) 1993-05-15
KR910002443A (ko) 1991-02-25
CN1041600C (zh) 1999-01-13
KR930000048B1 (ko) 1993-01-06
GR3007793T3 (no) 1993-08-31
NO177484B (no) 1995-06-19
EP0407815A3 (en) 1991-02-27
JPH03128322A (ja) 1991-05-31
FI96169B (fi) 1996-02-15
ES2055227T3 (es) 1994-08-16
DK0407815T3 (da) 1993-06-01
FI96169C (fi) 1996-05-27
FI903030A0 (fi) 1990-06-15
NO903058L (no) 1991-01-11
US5139740A (en) 1992-08-18

Similar Documents

Publication Publication Date Title
NO2002009I2 (no) Tiotropium
DK232989A (da) Antiviralt praeparat
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
IT1228288B (it) Composti ad attivita' antiserotoninica
SE8600017D0 (sv) New compound
NO903058D0 (no) Farmasoeytisk preparat med forbedret absorberbarhet.
DE69001734D1 (de) Aeusserlich anzuwendende amusulosin enthaltende arzneizubereitung.
EP0103320A3 (en) Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them
FI900145L (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
ZA933455B (en) Thiochroman compounds, processes for the preparation thereof and pharmaceutical compositions containing them
NO883520D0 (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
PT87628A (pt) Process for the preparation of a fungicidal composition cintaining (2-cyano-2-oxyminoacetyl)-aminoacids derivatives
DE69108580D1 (de) Optisch aktives Derivat der d-2-(6-Methoxy-2-naphthyl)-propionsäure und es enthaltende pharmazeutische Zusammensetzungen.
CA2022323A1 (en) Excretion of potassium ion by prostanoic acid derivatives
EP0080592B1 (en) A novel vasodilator compound, process for the preparation thereof and pharmaceutical compositions thereform
DE69206321D1 (de) Ursane Derivate, ihre Herstellung und die enthaltende pharmazeutische Zusammensetzung.
NO178137C (no) Fremgangsmåte for fremstilling av et polyprenylholdig farmasöytisk preparat i form av harde kapsler
ATE109454T1 (de) Catecholaminester.